Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rozman

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Clinical and Experimental Rheumatology|March 1, 1997
Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patientsV Jevtic, I Watt, B Rozman, et al.
Journal of Clinical Immunology|May 1, 1992
Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseasesN Zurgil, R Bakimer, H M Moutsopoulos, et al.
Lupus|June 20, 2007
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrualJ Nossent, N Cikes, E Kiss, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
Lupus|November 3, 2009
Common infectious agents prevalence in antiphospholipid syndromeH Zinger, Y Sherer, G Goddard, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Lupus|April 9, 2010
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosusJ Nossent, E Kiss, B Rozman, et al.
Lupus|July 22, 2010
Prolactin's role in the pathogenesis of the antiphospholipid syndromeS Praprotnik, N Agmon-Levin, B S Porat-Katz, et al.
British Journal of Rheumatology|December 1, 1996
Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritisV Jevtic, I Watt, B Rozman, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
Lancet (London, England)|February 3, 1999
Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study GroupJ S Smolen, J R Kalden, D L Scott, et al.
Clinical and Experimental Rheumatology|March 1, 1997
Contrast enhanced Gd-DTPA magnetic resonance imaging in the evaluation of rheumatoid arthritis during a clinical trial with DMARDs. A prospective two-year follow-up study on hand joints in 31 patientsV Jevtic, I Watt, B Rozman, et al.
Journal of Clinical Immunology|May 1, 1992
Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseasesN Zurgil, R Bakimer, H M Moutsopoulos, et al.
Lupus|June 20, 2007
Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrualJ Nossent, N Cikes, E Kiss, et al.
Scandinavian Journal of Rheumatology|July 27, 2001
Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazineA Larsen, T K Kvien, M Schattenkirchner, et al.
Lupus|November 3, 2009
Common infectious agents prevalence in antiphospholipid syndromeH Zinger, Y Sherer, G Goddard, et al.
The Journal of Rheumatology|September 12, 2001
Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study GroupJ R Kalden, D L Scott, J S Smolen, et al.
Lupus|April 9, 2010
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosusJ Nossent, E Kiss, B Rozman, et al.
Lupus|July 22, 2010
Prolactin's role in the pathogenesis of the antiphospholipid syndromeS Praprotnik, N Agmon-Levin, B S Porat-Katz, et al.
British Journal of Rheumatology|December 1, 1996
Prognostic value of contrast enhanced Gd-DTPA MRI for development of bone erosive changes in rheumatoid arthritisV Jevtic, I Watt, B Rozman, et al.
Pageof 11